Prediction of significant liver fibrosis in kidney transplant patients with chronic hepatitis C virus infection: The TX-3 index

Journal of Viral Hepatitis

Volumn 17, Issue 6, 2010, Pages 391-399

  Schiavon, L L ^a   Carvalho Filho, R J ^a   Narciso Schiavon, J L ^a   Pinheiro, S R ^a   Barbosa, D V ^a   Lanzoni, V P ^b   Ferraz, M L G ^a   Silva, A E B ^a  

^a Hepatitis Section   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hepatitis C; Kidney transplant; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; INTERFERON; BIOLOGICAL MARKER; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS C; HUMAN; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; BLOOD; COMPLICATION; EVALUATION STUDY; LIVER CIRRHOSIS; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

ADULT; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; PROGNOSIS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 77952257283     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01190.x     Document Type: Article

References (35)

1. Kumagai J., Komiya Y, Tanaka J et al. Hepatitis C virus infection in 2,744 hemodialysis patients followed regularly at nine centers in Hiroshima during November 1999 through February 2003. J Med Virol 2005 76 : 498 502.
2. Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Folsch UR, Schmidt WE. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut 2002 51 : 429 433.
3. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005 5 : 1452 1461. (Pubitemid 40839438)
4. Mathurin P, Mouquet C, Poynard T et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999 29 : 257 263.
5. Zylberberg H, Nalpas B, Carnot F et al. Severe evolution of chronic hepatitis C in renal transplantation: a case control study. Nephrol Dial Transplant 2002 17 : 129 133.
6. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Kanwal F, Dulai G. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transplant 2005 5 : 2433 2440.
7. Fabrizi F, Lunghi G, Dixit V, Martin P. Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients. Aliment Pharmacol Ther 2006 24 : 1413 1422.
8. Yasumura T, Nakajima H, Hamashima T et al. Long-term outcome of recombinant INF-alpha treatment of chronic hepatitis C in kidney transplant recipients. Transplant Proc 1997 29 : 784 786.
9. Tang S, Cheng IK, Leung VK et al. Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin. J Hepatol 2003 39 : 875 878.
10. Rostaing L, Izopet J, Baron E et al. Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients. Nephrol Dial Transplant 1995 10 (Suppl 6 93 96.
11. Shu KH, Lan JL, Wu MJ et al. Ultralow-dose alpha-interferon plus ribavirin for the treatment of active hepatitis C in renal transplant recipients. Transplantation 2004 77 : 1894 1896.
12. Durlik M, Gaciong Z, Rowinska D et al. Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients. Transpl Int 1998 11 (Suppl 1 S135 S139.
13. Toth CM, Pascual M, Chung RT et al. Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. Transplantation 1998 66 : 1254 1258.
14. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001 344 : 495 500.
15. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002 97 : 2614 2618.
16. Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003 38 : 427 432.
17. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003 38 : 1449 1457. (Pubitemid 37466971)
18. Scheuer PJ. Liver biopsy size matters in chronic hepatitis: bigger is better. Hepatology 2003 38 : 1356 1358.
19. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983 148 : 839 843.
20. Poynard T, Halfon P, Castera L et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 2007 53 : 1615 1622.
21. Cottone S, Palermo A, Vaccaro F et al. In renal transplanted patients inflammation and oxidative stress are interrelated. Transplant Proc 2006 38 : 1026 1030. (Pubitemid 43833230)
22. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005 16 : 3015 3026.
23. Perez RM, Ferreira AS, Medina-Pestana JO, Lanzoni VP, Silva AE, Ferraz ML. Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection? Clin Transplant 2005 19 : 622 625.
24. Fehr T, Riehle HM, Nigg L et al. Evaluation of hepatitis B and hepatitis C virus-infected renal allograft recipients with liver biopsy and noninvasive parameters. Am J Kidney Dis 2003 42 : 193 201.
25. Varaut A, Fontaine H, Serpaggi J et al. Diagnostic accuracy of the fibrotest in hemodialysis and renal transplant patients with chronic hepatitis C virus. Transplantation 2005 80 : 1550 1555.
26. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 38 : 518 526.
27. Kelleher TB, Mehta SH, Bhaskar R et al. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol 2005 43 : 78 84.
28. Macias J, Giron-Gonzalez JA, Gonzalez-Serrano M et al. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut 2006 55 : 409 414.
29. Sterling RK, Lissen E, Clumeck N et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006 43 : 1317 1325.
30. Schiavon LL, Schiavon JL, Filho RJ et al. Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection. Hepatology 2007 46 : 307 314.
31. Kamar N, Rostaing L, Selves J et al. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant 2005 5 : 1704 1712.
32. Alric L, Di-Martino V, Selves J et al. Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection. Gastroenterology 2002 123 : 1494 1499.
33. Perez RM, Ferreira AS, Silva IS et al. Hepatitis C virus infection in renal transplant patients: a comparative study with immunocompetent patients. Clin Transplant 2005 19 : 763 768.
34. Campbell MS, Constantinescu S, Furth EE, Reddy KR, Bloom RD. Effects of hepatitis C-induced liver fibrosis on survival in kidney transplant candidates. Dig Dis Sci 2007 52 : 2501 2507.
35. Westin J, Lagging LM, Wejstal R, Norkrans G, Dhillon AP. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 1999 19, 169 170.